Home Patent Forecast® Sectors Log In   Contact  
How it works Patent Forecast® Sectors Pricing Insights
Enjoy your FREE PREVIEW which shows only 2021 data and 25 documents. For full access, try it free at any time.        

AI Biotech/Diagnostics: Cardio

Read More News and Insights

Pill to replace insulin injections completes first human study

AI Biotech/Diagnostics: Cardio Patent Forecast®

March 5, 2019

Rani Therapeutics, a Silicon Valley company backed by Alphabet, has completed its first human study of its RaniPill, a pill capable of delivering biologic drugs such as insulin and AbbVie’s Humira into the wall of the small intestine. Alphabet is investing in other areas of biotechnology as well, indicated by Google's recently filed patent application for a system that uses AI to remotely monitor patients or babies sleeping.

Relevant Patent Documents

Application US20190065862  

Article Source Link


Read more like this in News This Week!   or   Share this link with your connections!